Olfactory memory in rats, cholinergic agents and benzodiazepine receptor ligands.
Drugs and their effects on olfactory learning processes in rats were tested using a modified version of the runway apparatus developed by Ades. Rats were first exposed to a conspecific urine sample and 24 h later were exposed to the same stimulus in the runway. Observations recorded the time spent investigating the urine and the number of sniffs at the site, these being considered to be indices of memory. Diazepam-treated rats (4 or 6 mg/kg) and scopolamine-treated rats (0.5 or 1 mg/kg) showed increases for both parameters. When both drugs were administered simultaneously, the impairing effect was potentiated. However, no changes in learning responses were observed in rats treated with physostigmine (0.125, 0.25, 0.5 mg/kg) or methyl beta-carboline-3-carboxylate (0.3, 0.5, 1 mg/kg), although the administration of physostigmine or methyl beta-carboline-3-carboxylate was shown to antagonize the impairing effect of diazepam or scopolamine respectively. These observations support the hypothesis of interactions existing between cholinergic agents and benzodiazepine receptor ligands and of such interactions affecting olfactory acquisition processes. The runway apparatus appears to be a valid candidate model to be used for the assessment of pharmacological influences on olfactory learning in rats.
Laboratoire de Pharmacologie du Comportement, Centre d'Etudes du Bouchet, Vert-Le-Petit, France.
F
F
Anglade
G
G
Chapouthier
R H
RH
Dodd
C
C
Baudoin
D000818:Animals; D002243:Carbolines / Q000494:pharmacology; D018678:Cholinergic Agents / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D003463:Cues; D003975:Diazepam / Q000494:pharmacology; D004347:Drug Interactions; D058785:GABA-A Receptor Agonists; D007858:Learning / Q000187:drug effects / Q000502:physiology; D008024:Ligands; D008297:Male; D008568:Memory / Q000187:drug effects* / Q000502:physiology; D018727:Muscarinic Antagonists / Q000494:pharmacology; D009812:Odorants; D009833:Olfactory Pathways / Q000502:physiology*; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011963:Receptors, GABA-A / Q000187:drug effects*; D012601:Scopolamine / Q000494:pharmacology; D014556:Urine
D002243:Carbolines; D018678:Cholinergic Agents; D002800:Cholinesterase Inhibitors; D058785:GABA-A Receptor Agonists; D008024:Ligands; D018727:Muscarinic Antagonists; D011963:Receptors, GABA-A; D010830:Physostigmine; D012601:Scopolamine; C036150:beta-carboline-3-carboxylic acid methyl ester; D003975:Diazepam